Cargando…

Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis

Schistosomiasis has been widely disseminated around the world, and poses a significant threat to human health. Schistosoma eggs and soluble egg antigen (SEA) mediated inflammatory responses promote the formation of egg granulomas and liver fibrosis. With continuous liver injuries and inflammatory st...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhilong, Zhang, Lichen, Liang, Yinming, Lu, Liaoxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650140/
https://www.ncbi.nlm.nih.gov/pubmed/36389166
http://dx.doi.org/10.3389/fcimb.2022.1035765
_version_ 1784827947895488512
author Liu, Zhilong
Zhang, Lichen
Liang, Yinming
Lu, Liaoxun
author_facet Liu, Zhilong
Zhang, Lichen
Liang, Yinming
Lu, Liaoxun
author_sort Liu, Zhilong
collection PubMed
description Schistosomiasis has been widely disseminated around the world, and poses a significant threat to human health. Schistosoma eggs and soluble egg antigen (SEA) mediated inflammatory responses promote the formation of egg granulomas and liver fibrosis. With continuous liver injuries and inflammatory stimulation, liver fibrosis can develop into liver cirrhosis and liver cancer. Therefore, anti-fibrotic therapy is crucial to increase the survival rate of patients. However, current research on antifibrotic treatments for schistosomiasis requires further exploration. In the complicated microenvironment of schistosome infections, it is important to understand the mechanism and pathology of schistosomiasis-associated liver fibrosis(SSLF). In this review, we discuss the role of SEA in inhibiting liver fibrosis, describe its mechanism, and comprehensively explore the role of host-derived and schistosome-derived microRNAs (miRNAs) in SSLF. Inflammasomes and cytokines are significant factors in promoting SSLF, and we discuss the mechanisms of some critical inflammatory signals and pro-fibrotic cytokines. Natural killer(NK) cells and Natural killer T(NKT) cells can inhibit SSLF but are rarely described, therefore, we highlight their significance. This summarizes and provides insights into the mechanisms of key molecules involved in SSLF development.
format Online
Article
Text
id pubmed-9650140
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96501402022-11-15 Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis Liu, Zhilong Zhang, Lichen Liang, Yinming Lu, Liaoxun Front Cell Infect Microbiol Cellular and Infection Microbiology Schistosomiasis has been widely disseminated around the world, and poses a significant threat to human health. Schistosoma eggs and soluble egg antigen (SEA) mediated inflammatory responses promote the formation of egg granulomas and liver fibrosis. With continuous liver injuries and inflammatory stimulation, liver fibrosis can develop into liver cirrhosis and liver cancer. Therefore, anti-fibrotic therapy is crucial to increase the survival rate of patients. However, current research on antifibrotic treatments for schistosomiasis requires further exploration. In the complicated microenvironment of schistosome infections, it is important to understand the mechanism and pathology of schistosomiasis-associated liver fibrosis(SSLF). In this review, we discuss the role of SEA in inhibiting liver fibrosis, describe its mechanism, and comprehensively explore the role of host-derived and schistosome-derived microRNAs (miRNAs) in SSLF. Inflammasomes and cytokines are significant factors in promoting SSLF, and we discuss the mechanisms of some critical inflammatory signals and pro-fibrotic cytokines. Natural killer(NK) cells and Natural killer T(NKT) cells can inhibit SSLF but are rarely described, therefore, we highlight their significance. This summarizes and provides insights into the mechanisms of key molecules involved in SSLF development. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9650140/ /pubmed/36389166 http://dx.doi.org/10.3389/fcimb.2022.1035765 Text en Copyright © 2022 Liu, Zhang, Liang and Lu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Liu, Zhilong
Zhang, Lichen
Liang, Yinming
Lu, Liaoxun
Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
title Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
title_full Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
title_fullStr Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
title_full_unstemmed Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
title_short Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis
title_sort pathology and molecular mechanisms of schistosoma japonicum-associated liver fibrosis
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650140/
https://www.ncbi.nlm.nih.gov/pubmed/36389166
http://dx.doi.org/10.3389/fcimb.2022.1035765
work_keys_str_mv AT liuzhilong pathologyandmolecularmechanismsofschistosomajaponicumassociatedliverfibrosis
AT zhanglichen pathologyandmolecularmechanismsofschistosomajaponicumassociatedliverfibrosis
AT liangyinming pathologyandmolecularmechanismsofschistosomajaponicumassociatedliverfibrosis
AT luliaoxun pathologyandmolecularmechanismsofschistosomajaponicumassociatedliverfibrosis